Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Acute Treatment of Migraine
The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (โฅ 6 to \< 18 years of age).
Neptune City, NJ6โ17 yrsAll genders
See details & check eligibility